BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, December 2, 2024
See today's BioWorld
Home
» Unified FDA Panel Votes 15-0 Against ViroPharma’s Picovir
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Unified FDA Panel Votes 15-0 Against ViroPharma’s Picovir
March 20, 2002
By
Kim Coghill
No Comments
GAITHERSBURG, Md. A government panel on Tuesday flatly rejected ViroPharma Inc.’s application for Picovir, an investigational drug that reduces the duration of a cold by one day. (BioWorld Today)
BioWorld
